Human adipose tissue-derived stromal cell therapy prevents bone loss in ovariectomized nude mouse

Tissue Engineering - Part A

Volumn 18, Issue 9-10, 2012, Pages 1067-1078

  Cho, Sun Wook ^a   Sun, Hyun Jin ^a   Yang, Jae Yeon ^a   Jung, Joo Yeon ^a   Choi, Hyung Jin ^a   An, Jee Hyun ^a   Kim, Sang Wan ^a   Kim, Seong Yeon ^a   Park, Kyu Joo ^a   Shin, Chan Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; GYNECOLOGY; MAMMALS; POLYMERASE CHAIN REACTION; TISSUE;

BONE LOSS; BONE MASS; BONE MINERAL DENSITY; CELL THERAPY; ENGRAFTMENT; FLOW CYTOMETRY ANALYSIS; HUMAN ADIPOSE; IN-VITRO; NUDE MICE; OSTEOCALCIN; OSTEOGENIC DIFFERENTIATION; PARACRINE MANNERS; PHOSPHATE-BUFFERED SALINES; PREOSTEOBLASTS; QUANTITATIVE REAL TIME PCR; STROMAL CELLS; T CELLS; TRABECULAR BONES; WHOLE BODY;

BONE;

MUS MUSCULUS;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BIOLOGICAL THERAPY; BONE DENSITY; CYTOLOGY; FEMALE; HUMAN; METHODOLOGY; MOUSE; NUDE MOUSE; OSTEOPOROSIS; OVARIECTOMY; PHYSIOLOGY; STROMA CELL;

ADIPOSE TISSUE; ANIMALS; BONE DENSITY; FEMALE; HUMANS; MICE; MICE, NUDE; OSTEOPOROSIS; OVARIECTOMY; STROMAL CELLS; TISSUE THERAPY;

EID: 84860543884     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0355     Document Type: Article

References (57)

1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285, 785, 2001.
2. Miller, P.D. Safety of parathyroid hormone for the treatment of osteoporosis. Curr Osteoporos Rep 6, 12, 2008.
3. Abrahamsen, B., Eiken, P., and Eastell, R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 24, 1095, 2009.
4. Karsenty, G., and Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2, 389, 2002.
5. Rodan, G.A., and Martin, T.J. Therapeutic approaches to bone diseases. Science 289, 1508, 2000.
6. Seeman, E., and Delmas, P.D. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 354, 2250, 2006.
7. Franceschi, R.T., Yang, S., Rutherford, R.B., Krebsbach, P.H., Zhao, M., and Wang, D. Gene therapy approaches for bone regeneration. Cells Tissues Organs 176, 95, 2004.
8. Egermann, M., Baltzer, A.W., Adamaszek, S., Evans, C., Robbins, P., Schneider, E., and Lill, C.A. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 17, 507, 2006.
9. Franceschi, R.T., Wang, D., Krebsbach, P.H., and Rutherford, R.B. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 78, 476, 2000.
10. Lewandrowski, K.U., Nanson, C., and Calderon, R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J 7, 609, 2007.
11. Pelled, G., Turgeman, G., Aslan, H., Gazit, Z., and Gazit, D. Mesenchymal stem cells for bone gene therapy and tissue engineering. Curr Pharm Des 8, 1917, 2002.
12. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
13. Schaffler, A., and Buchler, C. Concise review: adipose tissuederived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 25, 818, 2007.
14. Black, L.L., Gaynor, J., Adams, C., Dhupa, S., Sams, A.E., Taylor, R., Harman, S., Gingerich, D.A., and Harman, R. Effect of intraarticular injection of autologous adiposederived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 9, 192, 2008.
15. Tapp, H., Deepe, R., Ingram, J.A., Kuremsky, M., Hanley, E.N., Jr., and Gruber, H.E. Adipose-derived mesenchymal stem cells from the sand rat: transforming growth factor beta and 3D co-culture with human disc cells stimulate proteoglycan and collagen type I rich extracellular matrix. Arthritis Res Ther 10, R89, 2008.
16. Banas, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Osaki, M., Kawamata, M., Kato, T., Okochi, H., and Ochiya, T. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26, 2705, 2008.
17. Kim, Y., Kim, H., Cho, H., Bae, Y., Suh, K., and Jung, J. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 20, 867, 2007.
18. Cho, S.W., Sun, H.J., Yang, J.Y., Jung, J.Y., An, J.H., Cho, H.Y., Choi, H.J., Kim, S.W., Kim, S.Y., Kim, D., and Shin, C.S. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther 17, 1979, 2009.
19. Kim, D., Cho, S.W., Her, S.J., Yang, J.Y., Kim, S.W., Kim, S.Y., and Shin, C.S. Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. Stem Cells 24, 1798, 2006.
20. Bellino, F.L. Nonprimate animal models of menopause: workshop report. Menopause 7, 14, 2000.
21. Cho, S.W., Yang, J.Y., Sun, H.J., Jung, J.Y., Her, S.J., Cho, H.Y., Choi, H.J., Kim, S.W., Kim, S.Y., and Shin, C.S. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells. Bone 44, 1069, 2009.
22. Gronthos, S., Franklin, D.M., Leddy, H.A., Robey, P.G., Storms, R.W., and Gimble, J.M. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189, 54, 2001.
23. Gundberg, C.M., Clough, M.E., and Carpenter, T.O. Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse. Endocrinology 130, 1909, 1992.
24. Perry, D. Patients' voices: the powerful sound in the stem cell debate. Science 287, 1423, 2000. (Pubitemid 30127123)
25. Wu, Y., Chen, L., Scott, P.G., and Tredget, E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25, 2648, 2007.
26. Lian, Q., Zhang, Y., Zhang, J., Zhang, H.K., Wu, X., Lam, F.F., Kang, S., Xia, J.C., Lai, W.H., Au, K.W., Chow, Y.Y., Siu, C.W., Lee, C.N., and Tse, H.F. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121, 1113, 2010.
27. Choi, Y.H., Kurtz, A., and Stamm, C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 22, 3, 2011.
28. Granero-Molto, F., Weis, J.A., Miga, M.I., Landis, B., Myers, T.J., O'Rear, L., Longobardi, L., Jansen, E.D., Mortlock, D.P., and Spagnoli, A. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27, 1887, 2009.
29. Kumar, S., Wan, C., Ramaswamy, G., Clemens, T.L., and Ponnazhagan, S. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther 18, 1026, 2010.
30. Sheyn, D., Rüthemann, M., Mizrahi, O., Kallai, I., Zilberman, Y., Tawackoli, W., Kanim, L.E., Zhao, L., Bae, H., Pelled, G., Snedeker, J.G., and Gazit, D. Genetically modified mesenchymalstem cells induce mechanically stable posterior spine fusion. Tissue Eng Part A 16, 3679, 2010
31. Sass, D.A., Liss, T., Bowman, A.R., Rucinski, B., Popoff, S.N., Pan, Z., Ma, Y.F., and Epstein, S. The role of the T-lymphocyte in estrogen deficiency osteopenia. J Bone Miner Res 12, 479, 1997.
32. Cenci, S., Weitzmann, M.N., Roggia, C., Namba, N., Novack, D., Woodring, J., and Pacifici, R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNFalpha. J Clin Invest 106, 1229, 2000.
33. Lee, S.K., Kadono, Y., Okada, F., Jacquin, C., Koczon-Jaremko, B., Gronowicz, G., Adams, D.J., Aguila, H.L., Choi, Y., and Lorenzo, J.A. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21, 1704, 2006.
34. Seeman, E. Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Curr Osteoporos Rep 2, 90, 2004.
35. Bagi, C.M., Ammann, P., Rizzoli, R., and Miller, S.C. Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif Tissue Int 61, 336, 1997.
36. Brown, J.P., Delmas, P.D., Malaval, L., Edouard, C., Chapuy, M.C., and Meunier, P.J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1, 1091, 1984.
37. Charles, P., Poser, J.W., Mosekilde, L., and Jensen, F.T. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acidcontaining protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 76, 2254, 1985.
38. Delmas, P.D., Malaval, L., Arlot, M.E., and Meunier, P.J. Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. Bone 6, 339, 1985.
39. Delmas, P.D., Demiaux, B., Malaval, L., Chapuy, M.C., Edouard, C., and Meunier, P.J. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. J Clin Invest 77, 985, 1986.
40. Bataille, R., Delmas, P., and Sany, J. Serum bone gla-protein in multiple myeloma. Cancer 59, 329, 1987.
41. Fischer, U.M., Harting, M.T., Jimenez, F., Monzon-Posadas, W.O., Xue, H., Savitz, S.I., Laine, G.A., and Cox, C.S., Jr. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18, 683, 2009.
42. Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M.P., Robbins, R.C., and Pelletier, M.P. Stem cell transplantation: the lung barrier. Transplant Proc 39, 573, 2007.
43. Zhang, X.S., Linkhart, T.A., Chen, S.T., Peng, H., Wergedal, J.E., Guttierez, G.G., Sheng, M.H., Lau, K.H., and Baylink, D.J. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. J Gene Med 6, 4, 2004.
44. Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson, B.L., Semprun-Prieto, L., Delafontaine, P., and Prockop, D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5, 54, 2009.
45. Rubio, D., Garcia-Castro, J., Martin, M.C., de la Fuente, R., Ciqudosa, J.C., Lloyd, A.C., and Bernad, A. Spontaneous human adult stem cell transformation. Cancer Res 65, 3035, 2005.
46. Tolar, J., Nauta, A.J., Osborn, M.J., Panoskaltsis Mortari, A., McElmurry, R.T., Bell, S., Xia, L., Zhou, N., Riddle, M., Schroeder, T.M., Westendorf, J.J., McIvor, R.S., Hogendoorn, P.C., Szuhai, K., Oseth, L., Hirsch, B., Yant, S.R., Kay, M.A., Peister, A., Prockop, D.J., Fibbe, W.E., and Blazar, B.R. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25, 371, 2007.
47. Miura, M., Miura, Y., Padilla-Nash, H.M., Molinolo, A.A., Fu, B., Patel, V., Seo, B.M., Sonoyama, W., Zheng, J.J., Baker, C.C., Chen, W., Ried, T., and Shi, S. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095, 2006.
48. Zhou, Y.F., Bosch-Marce, M., Okuyama, H., Krishnamachary, B., Kimura, H., Zhang, L., Huso, D.L., and Semenza, G.L. Spontaneous transformation of cultured mouse bone marrowderived stromal cells. Cancer Res 66, 10849, 2006.
49. Jeong, J.O., Han, J.W., Kim, J.M., Cho, H.J., Park, C., Lee, N., Kim, D.W., and Yoon, Y.S. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res 108, 1340, 2011.
50. Jung, H., Kim, H.H., Lee, D.H., Hwang, Y.S., Yang, H.C., and Park, J.C. Transforming growth factor-beta 1 in adipose derived stem cells conditioned medium is a dominant paracrine mediator determines hyaluronic acid and collagen expression profile. Cytotechnology 63, 57, 2011.
51. Kilroy, G.E., Foster, S.J., Wu, X., Ruiz, J., Sherwood, S., Heifetz, A., Ludlow, J.W., Stricker, D.M., Potiny, S., Green, P., Halvorsen, Y.D., Cheatham, B., Storms, R.W., and Gimble, J.M. Cytokine profile of human adipose-derived stem cells, expression of angiogenic, hematopoietic, and proinflammatory factors. J Cell Physiol 212, 702, 2007.
52. Ii, M., Horii, M., Yokoyama, A., Shoji, T., Mifune, Y., Kawamoto, A., Asahi, M., and Asahara, T. Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Lab Invest 91, 539, 2011.
53. Schipani, E., Maes, C., Carmeliet, G., and Semenza, G.L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res 24, 1347, 2009.
54. Chen, L., Tredget, E.E., Wu, P.Y., and Wu, Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3, e1886, 2008.
55. Lee, K., Kim, H., Kim, J.M., Kim, J.R., Kim, K.J., Kim, Y.J., Park, S.I., Jeong, J.H., Moon, Y.M., Lim, H.S., Bae, D.W., Kwon, J., Ko, C.Y., Kim, H.S., Shin, H.I., and Jeong, D. Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. J Cell Mol Med 15, 2082, 2010.
56. Van Harmelen, V., Rohrig, K., and Hauner, H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 53, 632, 2004.
57. Peptan, I.A., Hong, L., and Mao, J.J. Comparison of osteogenic potentials of visceral and subcutaneous adiposederived cells of rabbits. Plast Reconstr Surg 117, 1462, 2006.